Literature DB >> 1549203

How accurately can Parkinson's disease be diagnosed?

W C Koller1.   

Abstract

The clinical picture of Parkinson's disease (PD) can be so varied that absolute clinical diagnosis may not always be possible. Several diverse entities (including toxins, pharmacologic agents, and multisystem atrophies and other degenerative diseases) can produce clinical syndromes almost indistinguishable from those of PD. Nevertheless, a sufficient number of guiding criteria--such as the presence of at least two of three motor signs (tremor, bradykinesia, and rigidity), persistence of these signs for several years, and responsiveness to levodopa--may serve to clarify and specify diagnosis, at least until such time as a biologic marker of PD is discovered. However, currently the clinical diagnosis of PD remains difficult.

Entities:  

Mesh:

Year:  1992        PMID: 1549203

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  [Postmortal diagnosis of Parkinson's disease].

Authors:  D Sandmann-Keil; H Braak
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  Gastric myoelectrical activity in patients with Parkinson's disease: evidence of a primary gastric abnormality.

Authors:  I Soykan; Z Lin; J P Bennett; R W McCallum
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 4.  Different diagnostic criteria for Parkinson disease: what are the pitfalls?

Authors:  Roongroj Bhidayasiri; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2013-03-15       Impact factor: 3.575

5.  Impaired gastric myoelectrical activity in patients with Parkinson's disease and effect of levodopa treatment.

Authors:  Ching-Liang Lu; Din-E Shan; Chih-Yen Chen; Jiing-Chyuan Luo; Full-Young Chang; Shou-Dong Lee; Han-Chang Wu; J D Z Chen
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

6.  HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.

Authors:  H S Markus; D C Costa; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 7.  Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Bastiaan Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda M Halliday; John Hardy; Anthony E Lang; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2014-03-11       Impact factor: 10.338

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.